-PTI Commission upset over 'steep rise' in cases Chandigarh: The National Commission for Scheduled Castes on Friday expressed strong displeasure over the failure of Haryana, Punjab, Uttar Pradesh and Bihar governments to prevent "steep rise" in atrocities against people from weaker sections. "The commission is in the final stages of preparing a report card on the functioning of Haryana, Punjab, Bihar and UP governments regarding increase in cases of atrocities against Dalits," NCSC...

-The Hindu Dhule (Maharashtra): A teenage girl's degrading journey from a small village in Nashik to a brothel here ended in February, but no concrete steps have been taken to ensure that such stories do not repeat. Activists alleged that while the brothel-owners and some of their accomplices were arrested, the police chose to ignore a sex racket involving minor girls that is flourishing in the State. Speaking exclusively to The Hindu...

-Live Mint Government reaches near consensus as BJP agrees to support Bill in Parliament; industry not enthused by plan The government may be close to pulling off one of India's most significant policy changes with a near consensus among political parties on a new land acquisition law, taking the country to the verge of removing what's perceived as the biggest impediment to the next wave of industrialization. At the conclusion of an all-party...

-The Hindu Extracts show violence before and during funeral processions of kar sevaks In its closure report submitted to the trial court, the Special Investigation Team that probed Zakia Jafri's complaintagainst Narendra Modi and 58 others said there was no evidence to prove that the Chief Minister had sent the bodies of the 2002 Godhra victims to Ahmedabad with a view to parading them before the public. The SIT quoted Ahmedabad Police Commissioner...

The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...